Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients

WV Williams, PS Ong, A Abuhelwa, H Cui… - Targeted …, 2022 - books.google.com
Background: Mounting randomized clinical trials have proved that immune checkpoint
inhibitors (ICIs) achieved better overall survival (OS) and progression-free survival (PFS) …

Feiyanning Formula Induces Apoptosis of Lung Adenocarcinoma Cells by Activating the Mitochondrial Pathway

DH Yang, X Zhao - New Technologies in Cancer Diagnostics and …, 2021 - books.google.com
Paris polyphylla, and Polistes olivaceous, etc. All of them have been proved to have
antitumor effect. In this study, we used the TCM network pharmacological analysis to perform …

Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinoma

住谷隆輔, スミヤリュウスケ - 2022 - jair.repo.nii.ac.jp
Glutathione S-transferase omega 2 (GSTO2) lacks any appreciable GST activity, but it
exhibits thioltransferase activity. The significance of GSTO2 in lung function has been …

Comparative Clinical and Cost-Effectiveness Analysis of First-and Second-Line Therapies for the Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer in …

YJ Kim - 2021 - uwspace.uwaterloo.ca
Background: Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer-related deaths in Canada. Over the last decade, significant advancements in …

[PDF][PDF] Neutrophil-to-lymphocyte ratio as a prognostic marker in highly PD-L1 expressing advanced non-small cell lung cancer patients in first line treatment with …

L Gomes, S Pereira, J Dias, AM Figueiredo, F Barata… - Revista GECP, 2023 - gecp.pt
Introduction and objectives: The neutrophil-lymphocyte ratio (NLR) has been proposed to
assess advanced stage non-small cell lung cancer (aNSCLC) response to immunotherapy …

[PDF][PDF] Studying the chemosensitizing effect of Pirfenidone in non-small cell lung cancer cell lines

HI de Freitas Branco - 2021 - repositorio-aberto.up.pt
Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell
lung cancer (NSCLC) accounts for roughly 85% of the cases. Despite the advances that …

[HTML][HTML] Alternative splicing events in immune infiltration of lung adenocarcinoma

T Huang, W Ye, X Lin - Medical Science Monitor: International …, 2021 - ncbi.nlm.nih.gov
Results We found that exon skip (ES) and mutually exclusive exons (ME) exhibited the most
and least AS events, respectively. The risk score and stage of LUAD patients were strongly …

Immunotherapies For Cancer, a Promising Cure?

X Yang - Proceedings of the 1st International Symposium on …, 2020 - dl.acm.org
Cancer is a common cause of death around the world. To date, surgery is still the only
curative option for most types of cancer. Moreover, the majority of cancer is a prominent …

ĐẶC ĐIỂM LÂM SÀNG TRẦM CẢM Ở BỆNH NHÂN UNG THƯ PHỔI KHÔNG TẾ BÀO NHỎ

AT Dương, VD Nguyễn, VT Nguyễn - Tạp chí Y học Việt Nam, 2021 - tapchiyhocvietnam.vn
Tóm tắt Đặt vấn đề: Ung thư phổi thường gặp tại Việt Nam cũng như trên thế giới. Trong đó,
ung thư phổi không tế bào nhỏ chiếm khoảng 85-90%. Trầm cảm là một rối loạn tâm thần …